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A B S T R A C T   
Accurate mechanistic in vitro dissolution models can deliver insight into drug release behaviour and guide 
formulation development. Drug release profiles from drug-excipient granules can be impacted by variation of 
porosity and drug load within granules, which may arise from inherent variability in granulation processes. Here, 
we analyse and validate a recent model of drug release from a single spherical granule with a matrix of insoluble 
excipient, incorporating radial variation of porosity and drug load. The model is presented and specialised to the 
case where the initial drug load is large compared to the capacity of the granule’s pores at solubility. In this limit, 
the model reduces to a single ordinary differential equation describing depletion of a shrinking, drug-saturated 
core. Model validation is performed using drug release data from the literature for a granule system consisting of 
acetaminophen and microcrystalline cellulose. A new extended model to describe dissolution from a polydisperse 
collection of granules is derived. The performance is compared to single particle models using equivalent 
spherical diameters. The developed model provides a new tool to explore the dissolution parameter space for 
these systems and for considering the impact of radial variation of granule porosity and drug load arising from 
manufacturing processes.   
1. Introduction 
The development and design of orally administered drug products 
such as tablets and capsules is a huge area of research in the pharma-
ceutical industry. Recent industry-led white papers highlight the 
importance of establishing clinically relevant dissolution specifications 
(Hermans et al., 2017) and developing robust first-principles models to 
understand and predict in vitro dissolution testing behaviour (Zaborenko 
et al., 2019). The ability to mathematically model the release profile of 
an active pharmaceutical ingredient (API) based on information, 
including material properties, dissolution conditions, and formulation 
and process parameters, is seen as an important tool in early stage 
formulation development when the API may be available in limited 
quantities. Modelling of the complete process from initial tablet or 
capsule form to the end point of the dissolution process is a very chal-
lenging endeavour due to the existence of several dissolution mecha-
nisms, some of which may be occurring concurrently. These may include 
film-coat dissolution, tablet disintegration into granules, granule de- 
aggregation into API and excipient particles, or direct dissolution of 
API from intact tablet or granular matrices (Markl and Zeitler, 2017). 
The relative dominance of these processes and many complex sub- 
processes, including solvent imbibition, tablet and granule swelling, 
erosion and disintegration, as well as the local fluid dynamics in the 
dissolution apparatus combine to produce the observed dissolution 
profile. Nevertheless, the application of first-principles models in 
conjunction with targeted experiments can accelerate robust develop-
ment of a target release profile (Zaborenko et al., 2019). 
Despite their complexity, progress has been made in the modelling of 
various processes involved in dissolution of oral solid dosage forms 
(OSDs). Recent work includes modelling liquid transport and swelling 
(Lin et al., 2001; McCue et al., 2011; Hsieh, 2012; Markl et al., 2017; 
Markl and Zeitler, 2017), disintegration (Quodbach and Kleinebudde, 
2016; Desai et al., 2016), linking dissolution and disintegration (Wilson 
et al., 2012) and dissolution of a system of API particles (Wang et al., 
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2015). Each of these works adds to the collection of modelling tools 
available to understand dissolution behaviour of formulations during 
development. 
The focus of this study will be on dissolution of granular systems and 
in particular how their microstructure and size distribution may impact 
the dissolution profile. There are a number of experimental studies 
emphasising how microstructural inhomogeneities can arise due to 
physical behaviour occurring in granulation processes. Koide et al. 
(2013) studied the microstructure of granules in terms of the spatial 
location of the constituent using near infra-red (NIR) chemical imaging 
and reported segregation of components within the granules due to over- 
granulation. Kataria et al. (2018) investigated soluble component 
migration in granules during drying. They found that the soluble 
component leached out to the periphery of the granule, creating a non- 
homogeneous component distribution within the granule. Other studies 
have considered the cause of API and porosity variations in granules, as 
well as the effect of such variations on dissolution behaviour. Le et al. 
(2011) performed a detailed study on the impact of granulation mech-
anism on granule structure, binder content, porosity, and dissolution 
rate. They found that even granules of the same size and batch can have 
significant inhomogeneities in terms of all these properties. Granules 
formed through coalescence were more porous and dissolved faster. 
Ansari and Stepanek (2007) considered the impact of composition on 
granule dissolution time in a binary granule. They found that dissolution 
of faster dissolving species could be limited by surrounding slower dis-
solving species at lower mass fractions, while at high mass fractions its 
dissolution could be limited by its local saturation in the solvent which 
removes the driving force of extraction. Smrcka et al. (2018) considered 
the impact of granulator scale and settings on variation of the micro-
structure of granules including porosity. They found significant varia-
tion of properties both within and between batches leading to variable 
dissolution behaviour. Farber et al. (2003) observed that changing 
granulation settings altered the granule porosity by changing the size of 
pore channel diameters joining larger cavities, rather than changing the 
cavity sizes. Smrcka et al. (2016) outlined leaching, surface erosion and 
break-up as three elementary mechanisms of granule dissolution and 
showed that, depending on granulation conditions, sub-populations of 
granules may undergo dissolution via break-up (disintegration) and 
leaching or leaching alone. The overall dissolution curve is then a su-
perposition of the different dissolution curves of granules. Matsui et al. 
(2019) considered the effect of porosity variations in granules prepared 
by twin screw granulation on their disintegration-controlled dissolution 
and found higher porosity granules have lower strength and faster 
disintegration and dissolution. Kašpar et al. (2013) and Oka et al. (2015) 
investigated dissolution of porous binary granules via leaching. Kašpar 
et al. (2013) considered the impact of granule porosity on dissolution at 
a fixed drug mass fraction, while Oka et al. (2015) studied the impact on 
dissolution of drug content and porosity non-uniformities arising from 
different granulation conditions and drug mass fractions. Many of these 
studies made use of micro-CT imaging to determine drug and porosity 
distributions within the granules and highlight the need to develop 
dissolution models which can account for such microstructural 
variations. 
There are a vast range of studies of interest on mathematical 
modelling of dissolution processes from granules in various contexts 
including pharmaceutical settings. Although many advanced mecha-
nistic models have been developed, their mathematical complexity is a 
barrier to widespread use and many studies utilise empirical or simple 
mechanistic models such as the Noyes-Whitney or Nerst-Brunner equa-
tions (Dokoumetzidis and Macheras, 2006). Furthermore complex 
models require more data to parametrise in comparison to some simple 
models of the dissolution profile with a small number of fitting param-
eters. Nevertheless, more sophisticated models are needed to capture the 
effect of microstructural variations observed experimentally in granules. 
Siepmann and Siepmann (2008, 2012, 2013) provide an extensive re-
view of mathematical modelling of drug delivery from a range of 
systems governed by different limiting behaviours. Arifin et al. (2006) 
present an extensive review article on modelling drug release from 
polymeric microspheres, of direct relevance to modelling release from 
porous granules considered in this work. 
In this study, we will consider a recently developed model Moroney 
and Vynnycky, 2020 which describes dissolution of an API from a porous 
spherical granule of a specified radius with an insoluble excipient matrix 
and seek to validate and extend the model. The model describes the 
situation where the API undergoes dissolution via leaching and explic-
itly accounts for radial variations of API content and porosity within the 
granule, which may be a design feature or the result of a variable 
granulation process. The model provides the flexibility to explore these 
effects. In Section 2 we describe the key assumptions and equations of 
the model and how it can be approximated when the initial drug con-
centration in the granules is large compared to its saturation concen-
tration in the solvent. The model is then extended to describe dissolution 
from a polydisperse collection of granules with a given particle size 
distribution and again an approximate model is presented for high initial 
drug load. In Section 3 the single particle model is validated against 
experimental data in the literature for monodisperse granules with a 
range of granule sizes and porosities. The behaviour of the polydisperse 
model for a sample granule size distribution is compared with mono-
disperse models using equivalent spherical diameters to assess the loss in 
accuracy resulting from the monodisperse approximation. 
2. Mathematical modelling of granule dissolution 
In this work, we develop a dissolution model for a polydisperse 
system of porous granules consisting of an API which is soluble in the 
dissolution medium and an excipient matrix which is insoluble in the 
medium. The model here builds on a recently developed model for 
dissolution from monodisperse porous granules (Moroney and Vyn-
nycky, 2020). The key features of the monodisperse model are presented 
and analysed. Multiple particle sizes simulating a polydisperse system 
are modelled using a weighted sum of individual particle models. 
2.1. Single particle model for a monodisperse system 
We present the key assumptions and equations from the model 
derived in Moroney and Vynnycky (2020) necessary to validate and 
extend the work. The model considers a dry spherical granule with 
radius R consisting of a volume fraction of excipient ϕe, a volume frac-
tion of drug ϕd and a volume fraction of air (porosity) ϕ which satisfy 
ϕe +ϕd +ϕ = 1. (1)  
It is assumed that once the granule is introduced into the solvent, solvent 
infiltration is sufficiently fast relative to other processes that the granule 
pore space can be considered initially saturated with solvent. The 
following modelling assumptions also underpin the model development:  
1. The volume fractions ϕd,ϕe and ϕ are defined to depend on the radial 
coordinate r subject to Eq. (1).  
2. The excipient forms a percolating solid matrix which does not 
disintegrate and any swelling in the solvent is negligible. Thus, the 
granule radius is constant.  
3. Solvent infiltration and internal dissolution occur relatively quickly, 
so either diffusion through the internal pore network or mass transfer 
from the particle surface to the bulk solvent controls the extraction. 
Thus, internal drug dissolution is not modelled explicitly, rather it is 
assumed that solid drug dissolves quickly until either it is all dis-
solved or its dissolution is limited by its solubility in the solvent. The 
drug concentration is represented as mass of drug per volume of the 
pore space after the drug volume fraction ϕd has dissolved. The drug 
concentration cd(r,t), may vary with the radial coordinate. The initial 
drug concentration is calculated as 
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cd(r, 0) = cd0(r) =
ρdϕd(r)
ϕ(r)
, (2)  
where ϕ(r) is the final granule porosity and is given by ϕ(r) =
1 − ϕe(r).  
4. The drug saturation concentration (drug solubility) in the solvent at 
the given temperature and pH is denoted csat. If the initial condition 
in Eq. (2) has cd0(r) < csat there is sufficient solvent to dissolve all the 
drug and cd(r, t) corresponds to the drug concentration in the solvent. 
It is assumed mass transfer in the radial direction follows Fickian 
diffusion. Eq. (2) may also give concentrations which are above csat 
for some values of r. In this case, the concentration cd(r, t) represents 
both dissolved drug in the solvent at a constant concentration csat and 
the remaining undissolved immobile drug in solid form. In this case, 
there is no net radial mass flux in these domains as the solid is 
immobile and there is no concentration gradient in the solvent phase. 
To account for this, the drug mass flux in the radial direction is 








0 if cd > csat,
(3)  
where Dd is an effective diffusion coefficient through the granular 
pore space. The tortuous pore space means Dd is typically smaller 
than the drug diffusion coefficient in the bulk solvent Db. A similar 
approach is adopted to account for solubility limitations in a nu-
merical model to predict drug release from cylindrical tablets in 
Siepmann et al. (2013). 
The analysis in Moroney and Vynnycky (2020) shows that Eqs. (2) 
and (3) can lead to a variety of moving boundary value problems 
depending on the relationship between cd0(r) and csat. We provide a brief 
summary here. Regions with concentrations above or below the satu-
ration concentration are formed initially as determined by (2). Ac-
cording to Eq. (3), no transport can occur within regions with cd > csat 
and drug can only be extracted from these regions through their in-
terfaces with regions where cd⩽csat driven by the concentration gradient 
at the interface. To ensure mass balance, this transfer causes the inter-
face to recede, shrinking the drug-saturated region. If the function cd0(r)
crosses the saturation concentration csat at a number of radial positions, 
alternating regions above and below solubility with multiple moving 
boundaries are created. Alternatively, if cd0(r)⩽csat for all r, no interface 
exists and extraction proceeds by diffusion. Finally, if cd0(r) > csat for all 
r, the concentration is above saturation everywhere and no drug diffu-
sion can take place within the granule initially. However, the granule is 
in contact with external solvent initially at zero concentration at its 
surface. Thus, extraction can take place at this interface and mass 
balance leads to a moving boundary which recedes inwards as dissolu-
tion proceeds. The model will be presented, extended and compared 
with experimental data for this case, while noting additional moving 
boundaries can be treated with a similar analysis. A schematic of the 
dissolution process for a single particle where the initial drug concen-
tration is above saturation is shown in Fig. 1. 
2.1.1. Governing equations 
We outline the governing equations from Moroney and Vynnycky 
(2020), along with a brief description of the underlying process. We 
assume cd0(r) > csat for all r. The drug in a narrow region adjacent to the 
surface r = R will be depleted by mass transfer to the exterior solvent 
driven by the concentration gradient between the saturated pore fluid 
and the solvent adjacent to the granule. After a short transient, the 
concentration just inside the granule surface drops to the saturation 
concentration and diffusion is active. The existence of a narrow region at 
or below drug saturation concentration is assumed at t = 0. The 
boundary rd(t) between the drug-saturated core region, where no drug 
transport occurs, and the shell region rd(t) < r < R will propagate in-
wards as drug is transferred through the granule shell to its surface via 
diffusion. This process continues until the moving boundary reaches the 
centre of the sphere at some time t = tc. The time tc cannot be deter-
mined a priori, although methods exist to determine it accurately in 
order to limit numerical error (Vynnycky and Mitchell, 2015). For t > tc, 
extraction in all parts of the granule is governed by diffusion. 
Time t < tc. For t < tc, the concentration in the region 0 < r < rd(t) is 
given by its initial value 
cd(r, t) = cd0(r), (4)  
as no mass transport can take place. This represents immobile drug in 
solid form in equilibrium with dissolved drug in the solvent at satura-













, (5)  
where ϕ(r, t) = ϕ(r) is a specified function. The diffusion coefficient Dd 
in general may depend on the porosity and concentration. The boundary 
conditions at the granule surface and moving boundary are defined by 
ϕ(R)Dd
∂cd
∂r |r=R = − kf 2(cd(R, t) − cb(t)), (6)  
cd(rd, t) = csat. (7)  
This assumes that mass transfer from the granule surface to a well-mixed 
fixed solvent volume Vb with concentration cb(t) is proportional to the 








Fig. 1. Schematic of dissolution process in a spherical granule of radius R where the initial drug concentration in the granule is above API saturation concentration. 
Dissolution proceeds via diffusion through a porous shell surrounding a shrinking API saturated core with radius rd(t) where no transport takes place for r < rd(t). The 
moving boundary position rd(t) is depicted at times 0 < t1 < t2. Figure reproduced from Moroney and Vynnycky (2020). 
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boundary, the concentration is set equal to the saturation concentration 
to ensure continuity of concentration in the pores at r = rd(t). 
The equation governing the moving boundary position is derived in 
Moroney and Vynnycky (2020) by applying conservation of mass to the 
granule, that is the rate of change of mass in the granule is balanced by 






(cd0(rd) − csat), (8)  
where rd(0) = R. An equation is also required for the evolution of the 
concentration cb(t) in the external solvent medium. Often sink condi-
tions are assumed and the approximation cb(t) ≈ 0 is used. However, if 
the experimentalist wants to observe different parts of the extraction 
profile, sink conditions might not be used. In order to maintain gener-
ality, the concentration can be determined by applying conservation of 
drug to the full system. In the monodisperse case, a number of particles 
N0 with radius R are dissolving into a well-mixed solvent volume Vb. The 






, (9)  









. (10)  
Now the rate of change of mass in the granule balances the rate it leaves 
the granule at r = R, so 
dmd
dt
= − 4πR2kf 2(cd(R, t) − cb(t)). (11)  








4πR2kf 2(cd(R, t) − cb(t))
)
, (12)  
with cb(t) = 0. Setting N0 = 1 reduces to the case of a single granule. 





(md0 − md(t)), (13)  
where md(t) is defined by Eq. (10) and md0 = md(0) is the initial mass of 
drug in a particle. The fractional amount of drug released at time t is an 
important quantity in dissolution modelling. In the monodisperse case, 




. (14)  
The full problem can be solved using Eqs. (5)–(8) with initial conditions 
and either Eq. (12) with initial condition or Eq. (13). When Eq. (13) is 
used, it can be substituted into Eq. (6), reducing the number of equations 
to be solved by one. 
Time t⩾tc. The equations for t⩾tc change, as there is no moving 
boundary. Eq. (8) is replaced by rd(t) = 0 and the problem domain is 
0 < r < R. Eq. (7) is replaced by a symmetry condition at r = 0 given by 
∂cd
∂r |r=0 = 0. (15)  
The surface boundary condition, the governing diffusion Eq. (5) and the 
bulk concentration equation remain unchanged. The concentration cd(r,
tc), got from solving the system for t < tc, completes the problem 
description. If the initial concentration in (4) satisfies cd0(r) < csat for all 
r, that problem can be solved by setting tc = 0 and rd(t) = 0 and just 
solving the equations for t⩾tc for all t > 0. 
2.1.2. Estimation of pore diffusion and mass transfer coefficients 
Most model parameters are relatively easy to determine but Dd and 
kf2 require some consideration. Many models use an effective diffusion 
coefficient, Deff , through the granule volume rather than the granule 
pore space, which is used here to explicitly account for variations in 
porosity. For a constant porosity, these coefficients are related by Deff =
ϕDd. These effective diffusion coefficients are often related with the 
drug diffusion coefficient in free solvent Db. The relationship depends on 
the porous medium tortuosity, which is often linked with porosity 
through relations such as the Bruggeman relation described in Brugge-
man (1935) and Tjaden et al. (2016). Various functional relationships 
are used in the literature including Millington (1959) and Pisani (2011). 
In this work, the ability of a general power-law relationship of the form 
Dd(ϕ) = Dbaϕm, (16)  
to capture the relationship between the effective pore diffusion coeffi-
cient and the granule porosity for granules of different porosities, is 
assessed. 
The rate constant kf2 can be estimated in different ways. Typically, it 
is defined as a mass transfer coefficient based on diffusion of solute 
through a thin layer of thickness hdiff adjacent to the particle surface. The 
estimation of the layer thickness is important to accurately determine 
mass transfer at the particle surface and depends in general on the 
interaction between the particle and the fluid velocity field in the 
dissolution apparatus. The impact of hydrodynamics on solid drug 
particle dissolution in a flow-through dissolution apparatus was 
considered in D’Arcy and Persoons (2011, 2019), by calculating an 
average relative velocity between the dissolution medium and the par-
ticle and applying the Ranz-Marshall correlation (Ranz and Marshall, 
1952). While this is important for surface-limited dissolution of a 
shrinking particle, an approach similar to Hintz and Johnson (1989) is 
adopted here. The diffusion-layer thickness is determined as a constant 
value for particles with a radius greater than some cutoff value and equal 
to the particle radius for radii less than this value. As the granule radii in 
this study stay fixed over the dissolution time and extraction is expected 
to be limited by internal mass transfer, a constant mass transfer coeffi-




, (17)  
where hdiff = 30μm is taken as a representative value from Hintz and 
Johnson (1989). In comparison to Hintz and Johnson (1989), this will 
underestimate surface mass transfer for particles with radii less than 30 
μm, but this is unimportant provided internal mass transfer is rate- 
limiting (see Section 2.2). Also the typical granules considered have 
radii well in excess of 30 μm. If this is not the case, more complex 
modelling of the diffusion boundary layer could be added to the model. 
2.2. Model analysis and specialisation 
Non-dimensionalisation in Moroney and Vynnycky (2020) revealed 
that the model behaviour can be described using three dimensionless 
parameters. This is particularly useful to reduce the model based on an 
understanding of the dominant dissolution mechanisms, before gen-
eralising it to describe the case of dissolution of a polydisperse system of 









, (18)  
where cd0m denotes the maximum value of the initial drug concentration 
function cd0(r). The parameter ε is the ratio of the drug solubility in the 
solvent to the maximum initial concentration of drug in the granule per 
K.M. Moroney et al.                                                                                                                                                                                                                            
International Journal of Pharmaceutics 599 (2021) 120219
5
final pore volume. Restricting attention to the case where the drug 
concentration in the granule does not cross its saturation level inter-
nally, ε ≤ 1 indicates that we will have a moving-boundary problem, 
while ε > 1 indicates that dissolution can be modelled as diffusion 
through a variably porous sphere. The dominant behaviour depends on 
the timescales of different processes including the granule diffusion 
timescale τdiff = R2/Dd and the timescale for evolution of the moving 
boundary, τmb = (R2cd0m)/(Ddcsat) = τdiff/ε. Specifically for ε≪1 diffu-
sion may be considered as fast relative to the speed of the moving 
boundary. This small parameter can be exploited to find an approximate 
solution for ε≪1. The parameter Bi is equivalent to the commonly used 
mass transfer Biot number and determines the ratio of mass transfer at 
the granule surface to internal diffusive mass transfer. A large Biot 
number indicates that the mass transfer is limited by internal diffusion 
and mass transfer at the surface occurs on a much shorter timescale than 
diffusion. Conversely, Bi≪1 indicates mass transfer is limited by surface 
kinetics assuming that the porosity at the granule surface is O(1). If the 
relationship between kf2,Dd and particle size is known, the Biot number 
can be used to estimate at what particle size extraction changes from 
being limited by surface kinetics (smaller particles) to internal diffusion 
(larger particles) if such a transition happens. Using the adopted 




. (19)  
Given that typical granules have R≫hdiff and diffusion is hindered 
relative to the bulk solvent Db > Dd we expect Bi≫1 for granule sizes of 
practical interest. 
The final dimensionless parameter is Vr which gives the ratio of the 
total volume of particles VT to the volume of the bulk solvent. Multi-
plying Vr by the average granule porosity ϕ gives the ratio of the 
intragranular solvent volume to the extragranular solvent volume or the 
dilution factor for the drug. The associated mass ratio, denoted by Ṽr =
Vr/ε, represents the ratio of the mass of drug present in the granules to 
the total mass of drug that would be present in the bulk solvent at 
saturation concentration csat. Sink conditions can only be expected if 
Ṽr≪1 which for ε≪1 requires Vr ∼ O(ε2). Conversely, if the mass ratio is 
sufficiently high, the end point of dissolution is determined by drug 
saturation, with the dissolution medium becoming saturated with drug 
before a complete release from the granule occurs. This occurs when 
Ṽr > cd0mcd0ϕ, where cd0 is the radially averaged initial concentration in the 
granule, but will not be considered in this study. 
2.3. Leading-order model 
In case ε≪1, it was shown in Moroney and Vynnycky (2020) that the 
dynamics of the moving boundary and extraction behaviour can be 
accurately approximated by considering an asymptotic expansion of the 
dependent variables in terms of ε and considering the equations at 
leading order. In particular, Eq. (5) reduces to a quasi-steady diffusion 
equation. Integrating this and applying conditions (6) and (7) gives cd(r,
t) in terms of rd(t) and cb(t). This is then substituted into (8) and (12) to 
give coupled ordinary differential equations (ODEs) governing the 
leading-order behaviour of rd(t) and cb(t). Alternatively, the leading- 
order version of Eq. (13) can be used for cb(t). The form of these equa-
tions depends on the porosity function ϕ(r). For the purposes of this 
study it suffices to present the leading order equations in dimensional 
form for the specific case of a constant porosity ϕ. The interested reader 
is referred to Moroney and Vynnycky (2020) for the mathematical de-
tails of derivation and the case of a general porosity ϕ(r). The leading 




1 − kf 2RDd ϕ
(














) . (20)  
The leading order behaviour of the moving boundary rd(t) is governed 









)2 csat − cb(t)
1 − kf 2RDd ϕ
(
1 − Rrd(t)
), rd(0) = R, (21)  
where the leading order solution for the concentration in the bulk sol-






r2ϕcd0(r)dr. (22)  
Despite the dramatic simplification of the model equations, they still in 
general need to be solved numerically. Eq. (22) may be differentiated 
with respect to time to find the corresponding ODE for cb(t), which may 
be preferable depending on the method of numerical solution. When 


















, (23)  
where md0 is the total mass of drug in one particle initially. In this case, 







. (24)  
Unlike the full problem, extraction is complete in the leading order 
model when the moving boundary reaches the centre of the particle and 
the model does not have to be solved for t > tc. 
2.3.1. Sink conditions 
The approximation of sink conditions may be used when Vr ∼ O(ε2)
or less. The leading order equation for rd(t) is then uncoupled from the 










1 − kf 2RDd ϕ
(
1 − Rrd(t)
), (25)  
with rd(0) = 0. The equation for the fractional drug release is un-
changed. If the initial drug concentration does not depend on radius 
(cd0(rd) = cd0m), it is possible to find an analytic solution for rd(t) by 
integrating Eq. (25) 





The solution can be written down analytically but involves choosing one 
root of a cubic equation and is quite unwieldy and so will not be pre-
sented here. Practically speaking, the exact solution has no significant 
advantage over numerically solving Eq. (25) in this instance. However, 
Eq. (26) does allow the determination of the time tc and the exact so-
lution can be used to verify numerical schemes. It is also noted that 
implicit equations similar to (26) (albeit less tractable) can be derived 
for certain cases of non-uniform ϕ(r) and cd0(r) (e.g. a linear porosity 
profile). This allows the effect of these profiles on tc to be considered. 
2.3.2. Time for moving boundary to reach granule centre 
In the leading-order model, the time tc it takes for the moving 
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boundary to reach the centre determines the end point of dissolution. 
Setting rd(t) = 0 in Eq. 26, we find tc is given by 
tc =
cd0mR(kf 2R + 2Ddϕ)
6csatDdkf 2
. (27)  
It is straightforward to show that this time depends only on the timescale 
τmb and the dimensionless parameters Bi and ϕ (Moroney and Vynnycky, 
2020). 
2.4. Model generalisation for a polydisperse system of Np particle sizes 
We now extend the single particle model to describe dissolution of a 
collection of particles with different radii. In practice, the granule radii 
lie on a continuous scale, but we will approximate the granule size 
distribution by a collection of granules of Np discrete sizes defined by the 
radii R1 < R2 < … < Rj < … < RNp . The smallest particle class has a 
radius R1, while the largest particle class has a radius RNp . Each class of 
particles may have different radially dependent porosities ϕj(rj) and 
initial drug concentration distributions cd0j(rj) allowing variations in 
these properties for different particle sizes arising due to granulation 
mechanisms to be modelled. Mathematically, this description involves 
Np copies of Eqs. (4)–(8). A modified version of either (12) or (13) is also 
required. This is a straightforward extension mathematically, but prac-
tically it may be difficult to get reliable data to parametrise functional 
relationships for the radial distribution of porosity and drug content for 
different particle sizes. A rigorous derivation and non- 
dimensionalisation of the general model is not presented here, but 
rather the key equations are outlined and the generalisation of the 
leading order model with constant porosity and drug content across 
particle radius and particle size is presented by analogy with the 
monodisperse model for a single granule size. 
2.5. Generalisation of full model for polydisperse system. 
The polydisperse system consists of Np discrete particle sizes repre-
sented by spheres of radii Rj, where j = 1,2,…,Np. Each particle class has 
a number nj particles. It follows that the surface area Sj and volume Vj of 
particles in the j-th class are given by 
Sj = nj4πR2j , Vj = nj
4πR3j
3
. (28)  













. (29)  
The number fraction and volume fraction of the total distribution for 







. (30)  
The single particle equations can easily be generalised to the poly-
disperse case. The main change is the equation for the concentration in 
the bulk phase needs to account for sources of drug from each particle 
class. Also the moving boundary will reach the particle centre at a 
different time t = tcj for each particle class. The equations for the j-th 
class follow from the single particle section above. 
For t < tcj, no transport occurs in the region 0 < rj < rdj(t), so the 
concentration is given by 
cdj(rj, t) = cd0j(rj). (31)  













, (32)  
where ϕj(rj, t) = ϕj(rj) is a specified function of rj. The boundary con-




|rj=Rj = − kf 2j(cdj(Rj, t) − cb(t)), (33)  
cdj(rdj, t) = csat. (34)  
The condition on the moving boundary is active for t < tcj. For t⩾tcj, it is 
replaced by the symmetry condition 
∂cdj
∂rj
|rj=0 = 0. (35)  
The derivation of the equation governing the moving boundary position 
for the j-th particle is identical to that in the single particle case and 







(cd0j(rdj) − csat), (36)  
where rdj(0) = Rj. This equation is valid for t < tcj. For t⩾tcj it is replaced 
by rdj(t) = 0. 
It remains to derive the equation for the concentration in the bulk 









. (37)  




mdj(t), (38)  
with the initial mass being defined by mdT0 = mdT(0). Now applying 
conservation of mass we have 
Vbcb(t)+mdT (t) = mdT0. (39)  




(mdT0 − mdT(t)). (40)  
As in the case of the monodisperse model, we could perform a full 
dimensional analysis to identify the dominant terms. Rather than pre-
sent this here, we will use a specialised version of the model to illustrate 
its usefulness. Based on the analysis from the single particle model, we 
specialise to a constant porosity and initial concentration across all 
particles such that cd0j(rj) = cd0m and ϕj = ϕ. We also assume that the 
mass transfer coefficient and in-pore diffusion coefficients are inde-
pendent of particle size, so kf2j = kf2 and Ddj = Dd. Assuming εj = csatcd0mj =
csat
cd0m≪1, we reduce the individual models for the particle classes to 
leading-order models analogous to those developed for single granule 
dissolution. This gives the following set of quasi-steady diffusion models 
for each particle class coupled with an equation for the moving 
boundary. For t < tcj, no transport occurs in the region 0 < rj < rdj(t), so 
the concentration is given by 
cdj(rj, t) = cd0m. (41)  










= 0, (42) 
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The boundary conditions at the granule surface and moving boundary 




|rj=Rj = − kf 2(cdj(Rj, t) − cb(t)), (43)  
cdj(rdj, t) = csat. (44)  







(cd0m), (45)  
where rdj(0) = Rj. This equation is valid for t < tcj. For t⩾tcj, it is replaced 






























































where γj is the volume fraction of particles in class j. The assumptions of 
this model mean γj is also representative of the mass fraction of the total 















. (48)  












. (49)  
We can simplify this system further by solving the quasi-static diffusion 
equation for cdj(r, t) and substituting into the moving boundary equa-
tion. Proceeding in the same way as in the single particle case, we find 









)2 csat − cb(t)
1 − kf 2RjDd ϕ
(
1 − Rjrdj(t)
), rdj(0) = Rj. (50)  
The equation for each j is valid while rdj(t) > 0. Once the radius of the 
shrinking core reaches zero at time tcj, then rdj(t) = 0 for t⩾tcj. Given the 
parameter values and particle size distribution (determined by γj), we 
can solve the system of Eqs. (50) and (48) to find the position of the 
moving boundary and the concentration in the bulk solvent over time. 
Where sink conditions prevail (mdT0≪csatVb), Eq. (50) may be solved 
with cb(t) = 0. 
2.6. Numerical methods 
2.6.1. Numerical solution to leading order monodisperse and polydisperse 
models 
The leading-order shrinking-core model in Eq. (21) for a single 
particle size takes the form of an ODE evolving in time. The numerical 
solution can be calculated by partitioning the time domain into uniform 
grid of Nt points 0 = t1 < t2 < … < tNt and discretising the ODEs using 
finite differences. In this work, MATLAB® built-in solver ‘ode23s’ is 
used to solve these systems. The rate of the change of the moving 
boundary position is set to zero once the moving boundary reaches the 
particle centre. The time this event takes place is detected using the 
built-in ‘Events’ option. 
In the polydisperse case, the solution method is identical except it is 
implemented for each particle size class. A set of Np ordinary differential 
Eqs. (50) coupled through Eq. (48) are solved by discretising the time 
domain using finite differences, again adopting MATLAB® built-in 
solver ‘ode23s’. For each particle size, the derivative of the moving 
boundary is set to zero once it reaches the granule centre and has no 
further contribution to Eq. (48), which calculates the bulk solvent 
concentration. 
2.6.2. Numerical solution to full single particle model 
In order to evaluate the loss of information which occurs when using 
the leading-order model of Section 2.3 instead of the full model in 
Section 2.1.1, it is necessary to solve Eqs. 4,5,6,7,8 and (12) numerically. 
For the purposes of comparison with the leading-order model we solve 
the equations assuming sink conditions (Vr ≈ 0) and using a constant 
porosity and initial drug concentration. The solution to these equations 
is complicated by the need to solve the equations on a changing spatial 
domain. We adopt methods used in the solution of Stefan problems 
outlined in Mitchell and Vynnycky (2009). This involves using a coor-
dinate transform to fix the spatial domain. The transform chosen de-
pends on the boundary conditions and in particular is selected to ensure 
that the transformed problem is well-posed in the limit t→0. Details of 
the transformed problem and numerical implementation using the finite 
element method are included in Moroney and Vynnycky (2020). The 
numerical simulations of the full model included in this study were 
performed using COMSOL Multiphysics® v5.5. 
3. Results and discussion 
The accuracy of the developed model will be ascertained through a 
comparison with experiments on dissolution of acetaminophen (APAP) 
from a granular matrix of Avicel PH-200 (microcrystalline cellulose) 
published in Kašpar et al. (2013). This data was chosen as it describes 
dissolution of a granular system in a medium in which the API is soluble 
and the excipient is insoluble. It is also rather unique in the literature in 
that X-ray micro-tomography (micro-CT) is used to visualise how the 
microstructure of the granules evolves during dissolution. The micro-CT 
images showed that porosity increased initially at the surface and a 
sharp front developed between an outer shell where the porosity had 
increased substantially and a core region where the porosity appears 
largely unchanged. This core shrinks over time and its radial position is 
recorded. The availability of both the dissolution profile and the radial 
position allows for a more comprehensive assessment of the accuracy of 
the models presented here. 
Most of the parameter values necessary to parametrise the models 
are provided in Kašpar et al. (2013) or can be calculated directly from 
those provided. One parameter that is not provided is the pore-averaged 
diffusion coefficient, although an effective diffusion coefficient is esti-
mated from a discrete version of Fick’s first law at specific time points. In 
this work, we will use the pore-averaged diffusion coefficient to fit the 
model release profiles. The radial position of the moving boundary will 
not be fitted, but used to assess how well the model is capturing the 
observed microscale behaviour within the granule. 
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3.1. Model choice and parameter values 
The data from Kašpar et al. (2013) related to binary granules con-
sisting of approximately a 3:7 mixture of the API and excipient on a mass 
per mass basis. Dissolution was carried out on the granules in ethanol at 
25 ◦C. The data presented gives both a dissolution time series (% API 
dissolved over time) and a time evolution of a shrinking API core posi-
tion obtained from micro-tomography imaging. The API saturation 
concentration and diffusion coefficient in the dissolution medium are 
reported as 164 kg m− 3 and 6.3 × 10− 10m2s− 1 respectively. Granules are 
prepared for six different granulation conditions and sieved into 
different size fractions. This gives data for a range of particle sizes and 
porosities. It is shown that there is no significant change in drug loading 
across the different granulation conditions or sizes. Data on the initial 
and final porosities ϕ0 and ϕ allows the estimation of the drug volume 
fraction and the initial drug concentration. In the absence of details on 
radial dependence of either porosity or drug distribution within gran-
ules, we will assume both are uniformly distributed, although it is 
mentioned that some granules may have hollows/higher porosity re-
gions near their centres. The initial concentration cd0(r) is estimated 
from (2) using the reported API true density of 1260 kg m− 3. The data 
for each granule type is reported in Table 1, retaining the lettered 
sample reference labels from Kašpar et al. (2013). The Biot number 
cannot be determined a priori but in the context of large granules relative 
to the diffusion boundary layer hdiff and a hindered diffusion we expect 
Bi≫1 for all granules. The exact mass of granules used and volume of 
dissolution medium is not reported, but it is stated that the mass of 
granules was chosen to keep the concentration of the API in the disso-
lution medium more than forty times lower than the API saturation 
concentration, meaning Ṽr≪1. Based on the data, we proceed with the 
leading order model (ε≪1) and assume sink conditions Ṽr≪1. As ε is 
almost 0.3 for some granules, the loss in accuracy incurred using the 
leading-order model is assessed in Section 3.4. The mass transfer coef-
ficient kf2 estimated from Eq. (17) is 2.1 × 10− 5 ms− 1. 
3.2. Capturing dissolution behaviour with granule size 
The study in Kašpar et al. (2013) provides dissolution data for 
different sieved fractions of granules produced under the same condi-
tions (sample H) at the same API loading. This data is used here to assess 
the ability of our model to capture dissolution behaviour for different 
granule sizes by fitting Dd from release data for the size fraction 1.40 mm 
to 1.70 mm with the midpoint diameter of 1.55 mm chosen as repre-
sentative. The fitted diffusion coefficient is then used to predict the 
dissolution behaviour of the smaller size classes 1.00 mm to 1.18 mm 
and 0.60 mm to 0.84 mm using midpoint diameters of 1.09 mm and 
0.72 mm. The dissolution data provides two time-series for each disso-
lution corresponding to the percentage of API released and the per-
centage reduction in the radius of the API core rd(t). The data on 
percentage extraction pd(t) contains non-zero values at time zero pd0 
ranging from approximately 3% to 15%. The reason for this is not clear. 
One possible explanation is that it may be due to the presence of fine 
unformulated API which could not be separated from the granules. The 
model cannot fit this instantaneous release which shows no trend across 
granule porosity or size and so the data is rescaled as follows to remove 






, (51)  
giving a percentage extraction from 0% to 100% for each granule. This 
normalisation is applied to all granule extraction data. The parameter Dd 
is used to fit the drug release profile and the model prediction for the 
percentage reduction in rd(t), which was measured independently, is 
compared to the data. The fit is performed using the nonlinear least 
squares solver ‘lsqcurvefit’ in MATLAB® using the trust-region- 
reflective algorithm. The same fitting procedure is used in subsequent 
sections. The resulting model fit and predictions are shown in Fig. 2. The 
fitted release profile agrees well with the data for the large granules, 
while the model also captures the variation in release profile with 
granule size. The position of the moving boundary is only available for 
the large granules. This data is not fitted as only one free parameter in 
the model has been used. Qualitatively, the curve follows the same shape 
as the data but overpredicts the radial reduction. This difference may be 
related to difficulties in determining the exact location of the moving 
boundary as a single idealised radius, or indeed some deviation from the 
assumption of uniform radial API concentration and porosity. Never-
theless, the existence and estimation a moving boundary position with 
similar dynamics to that predicted by the model provides some valida-
tion of the model mechanisms. The good agreement across different 
particle sizes suggest that the model fitted can be used for in silico 
simulation of polydisperse data, assuming the model assumptions are 
Table 1 
Granule data from Kašpar et al. (2013).  
Granule ϕ0  ϕ  ϕd  cd0 (kg m
− 3)  ε  
H  0.070  0.240  0.170  892.50  0.184  
M  0.098  0.297  0.199  844.24  0.194  
L  0.182  0.357  0.175  617.64  0.266  
B  0.135  0.299  0.164  691.10  0.237  
T  0.117  0.293  0.176  756.86  0.217  
I  0.170  0.307  0.137  562.28  0.292   














Fig. 2. Release kinetics of API and radial reduction of API core are shown for three different sizes of the same granule type H. The effective diffusion coefficient is 
fitted using the release profile for the large granules (indicated by ‘F’). The model is used to predict the radial reduction% for the large granules and both the release 
profile and radial reduction % for the smaller granules (indicated by ‘P’). 
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met. The root mean squared error (RMSE) of the fitted API release curve 
for the large granules was 2.56%, while the corresponding RMSEs for the 
predicted curves for the medium and small granules were 5.51% and 
8.83%, respectively. 
3.3. Capturing dissolution behaviour for different granulation conditions 
and porosities 
The experimental design performed in Kašpar et al. (2013) produced 
6 granulated samples under different processing conditions. One of the 
key differences between granules was their porosities. First, we evaluate 
if our model can effectively fit the release data for each granule and 
compare the fitted value with the values estimated in Kašpar et al. 
(2013). Secondly, the ability of a single expression for diffusivity as a 
function of porosity with two free parameters to fit all granule data is 
assessed. If this model can capture the observed dissolution profiles, the 
model developed may be useful to explore the granule design space for 
both size and porosity. Using the leading-order model without radial 
dependence neglects these microstructural differences between gran-
ules, but their importance will be reflected in the quality of the fit 
attained. 
Fig. 3 shows the fitted behaviour for the release profiles for each of 
the granules as well as the associated radial decrease in the moving 
boundary position. The model performs well in fitting the release 
behaviour in each case with RMSEs ranging from 2.31% for the T sample 
to a maximum of 5.77% for the I sample. The radial reduction is also 
captured reasonably for most of the granules with only the T sample 
showing a major deviation. For the T sample, the radius of the API core 
shrinks to zero in the experiment after two hours, whereas in the 
simulation it takes just over four hours. The simulated radial decrease 
must take this long as the API is still being released at this point. While 
the model can still capture the API release, the discrepancy needs to be 
considered. One possibility is that the quasi-steady diffusion equation 
assumption leads to the difference, as the timescale of diffusion is only 
approximately a factor of four times shorter than the front movement. 
This is evaluated in Section 3.4. Alternatively, the dependency may be 
related to a different distribution of API or pore volume in the T granules 
(for example, the presence of cavities). If this were shown to be the case, 
the full model could be used to simulate these effects. The fitted pore- 
averaged diffusion coefficients are listed in Table 2. The granule aver-
aged diffusion coefficient Deff is also reported to allow comparison with 
Kašpar et al. (2013). We can see that the results give similar values and 
the samples are in the same rank order as the values reported from the 
discrete calculations in Kašpar et al. (2013). The associated Biot 
numbers for these granules (R = 0.775 mm) range from 198 for the 
sample L to 1449 for sample H. At a radius R = 30 μm, the Biot numbers 
range from 7.7 to 56. For smaller granules, the approach of Hintz and 
Johnson (1989) would lead to the Biot number being fixed at the values 
for R = 30 μm. In either case, we see that the mass transfer is limited by 
internal diffusion even for granules as small as 60 μm in diameter, which 
is much smaller than the typical size of granules produced in Kašpar 
et al. (2013). 
Using one fitting parameter for diffusion is useful, but requires each 
sample to be fitted separately. It is more desirable to understand diffu-
sion as a function of the granule properties (porosity) and the diffusion 
properties of the API in the solvent (Db). With this understanding, the 
model can be applied to granules of different porosities and the risk of 
overfitting is reduced. The empirical power-law relationship in Eq. (16) 
is used in the leading order model for Dd and the parameters a and m are 
fitted using the release profiles from 5 granule samples with each sample 
given equal weighting. The granule sample B is excluded from the fit due 
to inconsistent data on its porosity in Kašpar et al. (2013). The initial 
porosity is reported as 0.135 but this is inconsistent with the statement 
that samples H and B have the lowest porosity and a porosity of 0.082 for 




























Fig. 3. Release kinetics and evolution of the moving boundary are shown for (a) granule samples H, M and L and (b) granule samples B, T and I. Although the radial 
moving boundary is not fitted reasonable agreement is observed with the model with the exception of sample T. 
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sample B, estimated from figure 11 in the paper. Rather than assume one 
particular value, sample B is excluded from the fit here. We note the 
power-law relationship is evaluated in Kašpar et al. (2013) for their 
estimated diffusion coefficient, but based on the initial granule porosity 
before dissolution. The final porosity is used here based on the mecha-
nisms of extraction in the model. 
The results are shown in Fig. 4 and Deff values reported in Table 2. 
The RMSE for the API release curves over the fitted data points is 
4.3848%. The fitted values of the coefficients are a = 29.7718 and m =
5.1736. The fitted relationship shows the hindered effective diffusion 
coefficient Deff ranging from approximately 20 to 225 times smaller 
(sometimes called the hindrance factor Hf ) than diffusion in the bulk 
solvent over the porosity range considered here. It can be seen that 
overall the model performs well on samples H, M and L and the release 
profiles for T and I. Sample I is the only sample showing a big deviation 
from its optimal fit previously. This is not surprising as the steep tra-
jectory means similar fits result from a range of diffusion coefficients, as 
can be seen by the visually good fit in Fig. 3. 
3.4. Accuracy of leading order model 
The leading order model is less complex and allows easier fitting of 
the model to data as well as an easier model solution. However, it is 
necessary to consider the impact of this on the solution accuracy. In this 
section, we compare the solution of the full model for this data 
(assuming Ṽr≪1, Bi≫1, but ε ∼ O(1)) with the leading order model 
where ε≪1. Two granule samples, with low porosity (H) and high 
porosity (L), are chosen for comparison with corresponding values of ε =
0.1838 and ε = 0.2655. The granule size is R = 0.775 mm and the 
diffusion coefficients Dd are those in Table 2. The Biot numbers are 1449 
and 198 for samples H and L, respectively. First we compare the time tc 
at which the moving boundary reaches the centre as estimated theo-
retically by Eq. (27) and numerically by the leading-order and full 
models. For sample H, the theoretical estimate of 13.48 h agrees well 
with the time determined numerically for the leading order model of 
13.51 h. The time estimated in the numerical solution of the full model is 
12.95 h. For sample L, the theoretical estimate, leading-order model and 
full model give 1.28 h, 1.28 h and 1.19 h respectively. The agreement 
Table 2 
The effective diffusion coefficients fitted here are compared to those in Kašpar et al. (2013). The Deff estimates produced by directly using a power-law relationship with 
porosity are also reported.  
Granule Dd (fitted)  Deff (Kašpar et al., 2013)  Deff (fitted)  Deff (= Dbaϕm+1)   
(m2s− 1) (m2s− 1) (m2s− 1) (m2s− 1) 
H  1.12 × 10− 11 2.7 × 10− 12 2.70 × 10− 12 2.80 × 10− 12 
M  4.55 × 10− 11 8.4 × 10− 12 1.35 × 10− 11 1.04 × 10− 11 
L  8.18 × 10− 11 5.3 × 10− 11 2.92 × 10− 11 3.25 × 10− 11 
B  1.68 × 10− 11 4.3 × 10− 11 5.01 × 10− 11 - 
T  2.70 × 10− 11 1.5 × 10− 11 7.92 × 10− 12 9.59 × 10− 12 
I  7.20 × 10− 11 3.2 × 10− 11 2.21 × 10− 11 1.28 × 10− 11  




























Fig. 4. Release kinetics are shown for (a) granule samples H, M and L and (b) granule samples T and I. The diffusion coefficient has been fitted as a function of 
porosity across all granules (excluding B) using (16). 
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between the theoretical and numerical leading-order estimates merely 
confirms the accuracy of the numerical scheme used. As expected, the 
moving boundary reaches the centre faster when the full model is used 
compared to the quasi-static diffusion case, but the error is relatively 
small within the context of the accuracy of the experimental data. In the 
full model a small amount of drug release continues beyond t = tc cor-
responding to the remaining drug in the pores. The comparison between 
the simulated release profiles is shown in Fig. 5. The results show that for 
the values of ε considered here (ε≲0.3) there is no significant advantage 
to using the full model in the context of agreement with the release data. 
Naturally, for large values of ε, the error will increase and the full model 
will be needed to ensure sufficient accuracy. The leading-order model 
does provide sufficient accuracy here and thus will be used to consider 
modelling of a polydisperse system of granules as described in Section 
2.4. A comprehensive comparison of the dimensionless leading-order 
and full models is included in Moroney and Vynnycky (2020). 
3.5. Modelling a polydisperse system of granules 
In most practical situations, dissolution studies consider a distribu-
tion of granule sizes. The idealised situation of a single granule size is 
useful for model validation and calibration against a sieved sample, but 
unlikely to capture the dissolution behaviour of a distribution of gran-
ules. Despite this, it is convenient to represent the granule size distri-
bution by a single particle diameter (or radius) and so single particle 
models are commonly used. Two of the most commonly used repre-
sentative sizes are the volume weighted mean particle diameter (d4,3) 
and the Sauter mean diameter (d3,2), which is defined as the diameter of 
a sphere with the same surface area-to-volume ratio as the distribution. 
Each of these diameters emphasises different characteristics important 
during different phases of dissolution. Modelling the distribution as a 
single particle with a diameter d3,2 will be more accurate during the 
initial stages, while using a diameter d4,3 will be representative of 
extraction in the later phases of dissolution. Depending on the quantity 
of interest, one of these single particle models may be useful, however 
neither can capture the full dissolution profile. As an illustrative 
example we compare results of the polydisperse model outlined in 
Section 2.4 for a specified granule distribution with the single particle 
models corresponding to the volume mean diameter and the Sauter 
mean diameter. We chose the volume distribution of particles (by radius 
here) to be defined by a Weibull distribution γ(R) with a scale parameter 
λ = 0.7 mm and a shape parameter k = 4. The distribution is normalised 
so that the maximum size granule has a radius of Rmax = 1 mm. The 
corresponding continuous particle size frequency distribution γ(R) and 
cumulative distribution Γ(R) are 




























Fig. 5. Comparison between the full and leading-order model for (a) granule samples H and (b) granule sample L.  







Fig. 6. Granule discrete particle size distribution by volume (mass) for poly-
disperse simulation with Np = 50 particle bins. 
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)k . (52)  
The volume weighted and Sauter mean radii are calculated as Rv =
0.6627 mm and Rs = 0.5672 mm, respectively. For the polydisperse 
model, the continuous volume distribution (equivalent to the mass dis-
tribution here) is discretised into bins of equal width δR between zero 
and the maximum size. The representative particle size Rj of each bin is 
chosen as its midpoint. Other representative radii could be chosen for 
each bin, with diminishing effects for a large number of bins. A number 
Np = 50 bins is selected here to represent the distribution. The volume 
fraction assigned to each bin γj is calculated from the cumulative dis-
tribution function as γj = Γ(Rj + δR/2) − Γ(Rj − δR/2). The discrete 
frequency distribution is shown in Fig. 6. The granule properties cor-
responding to sample H are selected for simulation. 
The API release profiles are shown in Fig. 7. Initially the polydisperse 
model follows a profile similar to the single particle using the Sauter 
mean radius. This is expected as smaller particles in the distribution 
dominate the initial phase of extraction, having a greater mass of API 
close to the surface relative to their volume. Thus, in the early phases of 
extraction the surface mean radius is more representative of the release. 
As release proceeds, and smaller particles are exhausted of API, the 
behaviour is closer to that of the particle with mean volume radius. 
However, this particle completes its extraction after approximately 10 h. 
Beyond this, large particles in the distribution are still contributing to an 
extended release in the polydisperse model. This can be seen more 
clearly in the comparison between the radius of the API core over time 
for different radii. It can be seen that the largest particle in the distri-
bution with Rj = 0.99 mm takes just over 22 h to extraction fully, more 
than twice the time at which the mean volume particle is exhausted. The 
times taken for each model to reach 80% and 90% extraction are shown 
in Table 3, illustrating the difference in model predictions. 
Only a single example of a particle size distribution is shown here 
with one modal size. It is emphasised that single particle models may 
still be appropriate depending on the model accuracy required and 
especially where the granule distribution is expected to consist of a 
single modal size with a narrow peak. In early formulation development, 
the model difference reported in Table 3 may be acceptable. When 
greater accuracy is required and particularly where the granule distri-
bution is wide or multimodal (or both), it should be clear that a single 
particle model cannot capture the dynamics of dissolution and a poly-
disperse model should be used. The polydisperse model, applying the 
quasi-steady diffusion assumption, may represent an appropriate level 
of complexity in this case, while still being relatively straightforward to 
solve numerically. It is important to note that the leading-order poly-
disperse model is only valid when the initial concentration in each 
particle class is much larger than the drug saturation concentration 
(εj≪1). If this is violated, then the full polydisperse model may need to 
be solved to ensure accurate simulations at the cost of increased nu-
merical complexity. 
4. Conclusions 
First principles modelling to predict in vitro dissolution behaviour 
during product development, based on the physical and chemical 
properties of tablets, granules and their constituent APIs and excipients, 
is a methodology of growing importance. Key to this, is the development 
of a set of simulation tools to describe different dissolution regimes. In 
this study, a modelling framework is developed to describe dissolution 
from a granule, or distribution of granules, consisting of a soluble API 
and an insoluble excipient matrix. The work builds on a recent model for 
dissolution from a single spherical granule (Moroney and Vynnycky, 
2020) and extends it to describe dissolution of a distribution of granule 
sizes. A particular emphasis is placed on the case where the API is pre-
sent in sufficient quantities to saturate the intragranular pores with API, 
as a reduced order model may be used in this case. For a single granule, 
the problem can be modelled using a moving-boundary model for a 
shrinking API-saturated core, surrounded by a porous shell region 
through which diffusion takes place. The model allows for variation of 
API and porosity in the radial dimension of the granule and thus can be 
used to simulate potentially undesirable situations arising during gran-
ulation. These may include presence of hollow regions in the centre of 
granules or API migration to the granule surface or centre during 
granulation. 
The key features of the single granule model are presented carefully 
and the dependence on dimensionless parameters derived in Moroney 
and Vynnycky, 2020 is outlined. In particular, when the ratio of the API 
saturation concentration to the initial API concentration in the granule 
(represented by the dimensionless parameter ε) is small, the model can 



























Fig. 7. (a) Comparison between the polydisperse model and single particle models with radii Rv and Rs. The time each model reaches 80% release is marked. (b) The 
radius of the API core over time for selected particles in the polydisperse model. Release from the largest granule takes approximately 22 h to complete. The single 
particle models both reach complete extraction in less than 10 h. 
Table 3 
Dissolution time points for different models.  
Model Time 80% release Time 90% release 
Polydisperse 3.28 h 5.36 h 
Mean volume radius 3.72 h 5.50 h 
Sauter mean radius 2.72 h 4.05 h  
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be reduced to solving a single ODE for the evolution of the radius of a 
shrinking core of unextracted API. If the dissolution is performed in sink 
conditions, then an analytic solution can be found to the model and an 
estimate for the time when the shrinking core reaches the particle centre 
determined. 
The single particle model is then generalised to describe dissolution 
from a distribution of granules by approximating the distribution as a 
collection of Np discrete particle size classes, each of which is described 
by a single particle model. The volume fraction for each particle class 
can be derived from a measured particle size distribution. The resulting 
set of equations are coupled through the concentration in the bulk sol-
vent cb(t). By analogy with the single particle model, a leading order 
model for the polydisperse system is presented for the case where the 
ratio of the API saturation concentration to the initial API concentration 
in each granule size class is small (∊j≪1). 
Data from Kašpar et al. (2013) describing acetaminophen release 
from binary acetaminophen-Avicel PH-200 granules is used in order to 
validate the model. This data consists of API release profiles and data on 
evolution of a shrinking API core for a range of particle sizes and po-
rosities. Based on analysis of the dimensionless parameters, the leading 
order model is used. A uniform radial API concentration and porosity is 
assumed within the granule. Results show that the fitted model is 
capable of capturing dissolution behaviour across both granule size and 
porosity with reasonable accuracy. Despite not being fitted to the data 
on the position of the shrinking core, the model produces similar 
behaviour. Observed differences could be due to non-uniform API or 
porosity distributions in the granules, for example due to the presence of 
hollows at the granule centres. Further data is required to test this hy-
pothesis. The suitability of a power-law relationship to relate the 
effective granule diffusion coefficient with its porosity is also examined. 
The full model is solved numerically for specific cases to evaluate the 
error arising from using the leading order model. 
Finally, the polydisperse model is used to simulate dissolution of a 
specified distribution of granules with properties taken from Kašpar 
et al. (2013). The accuracy of single particle models using the mean 
volume radius and the Sauter mean radius is assessed and the impor-
tance of accounting for particle size distribution for multi-modal or wide 
size distribution is emphasised. 
The developed model provides another tool for understanding and 
predicting dissolution behaviour during product development. A num-
ber of extensions are possible to allow the model to be applied to a wider 
set of formulations. The assumption of an insoluble inert excipient may 
be relaxed to allow the excipient to erode, dissolve or swell. A first 
principles description of the solvent infiltration phase would also add 
significant benefit and allow the conditions under which rapid infiltra-
tion arises to be assessed. The possibility of granule disintegration is also 
an important phenomena to consider. Each of these extensions adds 
significant model complexity, however careful analysis may reveal 
parameter regimes where reduced order models, such as the leading 
order model presented here, can provide the necessary balance of 
complexity and practicality. 
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